Croda International (CRDA) – Research Analysts’ Weekly Ratings Updates

Croda International (LON: CRDA) recently received a number of ratings updates from brokerages and research firms:

• 7/29/2026 – Croda International had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a GBX 3,300 price target on the stock.
• 7/29/2026 – Croda International had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a GBX 3,500 price target on the stock.
• 7/29/2026 – Croda International had its price target raised by Citigroup Inc. from GBX 3,050 to GBX 3,200. They now have a “neutral” rating on the stock.
• 7/29/2026 – Croda International had its “buy” rating reaffirmed by Berenberg Bank. They now have a GBX 3,600 price target on the stock.

Insiders Place Their Bets

In other Croda International news, insider Steve Foots sold 73 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of GBX 2,840, for a total value of £2,073.20. In the last 90 days, insiders bought 25 shares of company stock valued at $72,490. 0.83% of the stock is owned by corporate insiders.

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.